A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]).

[1]  D. Baim,et al.  Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. , 2001, American heart journal.

[2]  D. Baim,et al.  Rheolytic thrombectomy with the Possis AngioJet: technical considerations and initial clinical experience. , 1999, The Journal of invasive cardiology.

[3]  M. Nobuyoshi,et al.  Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. , 1999, The American journal of cardiology.

[4]  David P Miller,et al.  Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block , 1998, Journal of the American College of Cardiology.

[5]  J. Muhlestein,et al.  "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. , 1997, Journal of the American College of Cardiology.

[6]  U. Rosenschein,et al.  Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase. , 1997, Circulation.

[7]  S. Zarich,et al.  Angioscopic predictors of early adverse outcome after coronary angioplasty in patients with unstable angina and non-Q-wave myocardial infarction. , 1996, Circulation.

[8]  P. Teirstein,et al.  Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. , 1996, Circulation.

[9]  R. Califf,et al.  Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. , 1995, Circulation.

[10]  W. O’Neill,et al.  Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. , 1995, Journal of the American College of Cardiology.

[11]  R. Califf,et al.  A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. , 1995, Circulation.

[12]  E. Topol,et al.  Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. , 1993, Journal of the American College of Cardiology.

[13]  V. Bufalino,et al.  Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up. , 1991, Journal of the American College of Cardiology.

[14]  J. Ross,et al.  Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes. , 1990, Circulation.

[15]  M. Kern,et al.  Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus. , 1988, The American journal of cardiology.

[16]  D. Holmes,et al.  Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. , 1985, Journal of the American College of Cardiology.

[17]  T. Ulbright,et al.  Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein bypass grafts. , 1984, Journal of the American College of Cardiology.

[18]  W. O’Neill,et al.  Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. , 1996, Journal of the American College of Cardiology.

[19]  Teirstein Ps,et al.  Urokinase infusion and stenting of older saphenous vein grafts. , 1995 .